共 21 条
[1]
Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results for the Women's Health Initiative Randomized Controlled Trial, JAMA, 288, pp. 321-333, (2002)
[2]
Hersh A.L., Stefanick M.L., Stafford R.S., National use of postmenopausal hormone therapy: Annual trends and response to recent evidence, JAMA, 291, 1, pp. 47-53, (2004)
[3]
Ettinger B., Grady D., Tosteson A.N., Pressman A., Macer J.L., Effect of the Women's Health Initiative on women's decisions to discontinue postmenopausal hormone therapy, Obstet Gynecol, 102, 6, pp. 1225-1232, (2003)
[4]
Breslau E.S., Davis W.W., Doner L., Eisner E.J., Goodman N.R., Meissner H.I., Rimer B.K., Rossouw J.E., The homone therapy dilemma: Women respond, J Am Med Womens Assoc, 58, pp. 33-43, (2003)
[5]
Grady D., Ettinger B., Tosteson A.N., Pressman A., Macer J.L., Predictors of difficulty when discontinuing postmenopausal hormone therapy, Obstet Gynecol, 102, 6, pp. 1233-1239, (2003)
[6]
Brett K., Madans J.H., Use of postmenopausal hormone replacement therapy: Estimates from a nationally representative cohort study, Am J Epidemiol, 145, pp. 536-545, (1997)
[7]
Lando J., Heck K.E., Brett K.M., Hormone replacement therapy and breast cancer risk in a nationally representative cohort, Am J Prev Med, 17, 3, pp. 176-180, (1999)
[8]
Kritz-Silverstein D., Barrett-Connor E., Oophorectomy status and bone density in older, hysterectomized women, Am J Prev Med, 12, pp. 424-429, (1999)
[9]
Jones J.B., Representations of menopause and their health care implications: A qualitative study, Am J Prev Med, 13, 1, pp. 58-65, (1997)
[10]
Busch H., Barth-Olofsson A.S., Rosenhagen S., Collins A., Menopausal transition and psychological development, Menopause, 10, 2, pp. 179-187, (2003)